Loading…
← CockpitCompetitor Analysis › 0108.HK SR Medical Technology Company LimitedOpen in the cockpit ↗

SR Medical Technology Company Limited0108.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Real Estate›Real Estate Development
Momentum leader 96
Mkt cap
$1.16B
US dollars, full cap
Free float
41%
of shares outstanding
$/day
$491,737
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
n/a
WACC 5.4%
Hurdle
n/a
no reverse DCF
Close · HKDHK$2.82
1D-2.4%
1W+4.8%
1M-0.5%
3M+58.9%
6M+18.5%
YTD+21.0%
1Y+34.3%
ATR %8.1%
52w lowhigh34.1% off high

What SR Medical Technology does

Employees: 428

SR Medical Technology at a glance

Size SR Medical Technology (0108.HK) is a Hong Kong Real Estate company (Real Estate Development) with a market value of $1.16B, the 547th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$2.82 on 18 Nov 2026.

Performance Over six months the shares gained 18.5%, against -11.9% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 3rd highest of 21 in its peer set.

Growth Revenue grew 24.5% over the last twelve months (peer median -2.7%); the operating margin is 3.6% (peer median 16.2%).

Relative performance

608010012021 May 202621 Aug 202618 Nov 20260108.HK 117Peer median 89
Six months, rebased to 100: SR Medical Technology against the median of its 20 peers (local-currency closes).

SR Medical Technology financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$404MHK$349MHK$340MHK$377MHK$392M
Revenue growth—+3%-10%-4%—
Gross profitn/an/aHK$337MHK$373MHK$382M
EBITDAHK$21.4MHK$67.4MHK$85.2MHK$144MHK$141M
Net income-HK$182M-HK$110M-HK$919M-HK$129M-HK$320M
Free cash flowHK$147MHK$14.2M-HK$42.3MHK$15.4M-HK$180M
Capital expenditureHK$1.26MHK$2.73MHK$1.15MHK$965,000HK$922,000
Total debtn/aHK$4.05BHK$3.83BHK$3.87BHK$3.56B

Quarterly statements and history in the cockpit →

SR Medical Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%+20%-20%-10%0%+10%00053417668923OPENMEQFOR0565FREY00812337ICAD15286007731030LOTUSDEVIRS000006600185AEDASADN0108.HK6-month return →1-month return →
Up and to the right = strong over both horizons. SR Medical Technology is the large dot.

SR Medical Technology competitors and peer comparison

How SR Medical Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

SR Medical Technology against its 20 peers (data as of 18 Nov 2026)
Measure0108.HKPeer medianRank in peer set
1-month return-0.5%-5.4%7th highest of 21
6-month return+18.5%-11.9%3rd highest of 21
Distance from 52-week high-34.1%-33.0%11th highest of 21
Revenue growth (TTM)+24.5%-2.7%4th highest of 21
Operating margin3.6%16.2%5th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
SR Medical Technology 0108.HKHong Kong$1.16B+18%+25%4%n/an/an/a
Wedge Industrial 000534.SZChina$1.16B-58%+4%10%n/an/an/a
Token 1766.TJapan$1.15B+4%+5%6%n/an/an/a
Tosei 8923.TJapan$1.18B+20%+14%23%n/an/an/a
Opendoor Technologies OPENUnited States$1.18B-71%-29%-19%n/an/an/a
Mainstreet Equity MEQ.TOCanada$1.14B+6%+5%60%n/an/an/a
Forestar FORUnited States$1.14B-14%-2%13%n/an/an/a
Art 0565.HKHong Kong$1.19B+15%+51%60%n/an/an/a
Frey FREY.PAFrance$1.19B-2%+45%49%n/an/an/a
China Overseas Grand Oceans 0081.HKHong Kong$1.20B-10%-3%5%n/an/an/a
Ichigo 2337.TJapan$1.12B-8%-17%29%n/an/an/a
Icade ICAD.PAFrance$1.22B-28%-9%17%n/an/an/a
Red Star Macalline 1528.HKHong Kong$1.11B-35%-3%-24%n/an/an/a
Tibet Urban Development & Investment 600773.SSChina$1.09B-63%-78%-124%n/an/an/a
Seazen 1030.HKHong Kong$1.24B-34%-35%16%n/an/an/a
Sri Lotus Developers and Realty LOTUSDEV.NSIndia$1.24B+71%+40%38%n/an/an/a
IRSA Inversiones y Representaciones SA Sponsored ADR IRSUnited States$1.08B-17%+9%42%n/an/an/a
Shenzhen Zhenye (Group) 000006.SZChina$1.08B-44%-56%0%n/an/an/a
Zhuhai Zhumian 600185.SSChina$1.08B-28%-49%17%n/an/an/a
AEDAS Homes AEDAS.MCSpain$1.07B+2%-25%10%n/an/an/a
First Sponsor ADN.SISingapore$1.07B-7%-8%22%n/an/an/a

Questions

Which companies are SR Medical Technology's closest peers?
The cockpit's peer set: Wedge Industrial (000534.SZ), Token (1766.T), Tosei (8923.T), Opendoor Technologies (OPEN), Mainstreet Equity (MEQ.TO), Forestar (FOR), Art (0565.HK), Frey (FREY.PA).
How has SR Medical Technology stock performed?
Over six months to 18 Nov 2026 the shares returned +18.5% against -11.9% for the median peer; over one year +34.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.